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Diseases caused by I h s i n i o  enterocolitica serotype 0:3 in 
humans are often coniplicated by reactive inflamma- 
tions ofjoints [l-31. I t  is known that the temperature 
regulation of yersinia virulence factors plays an 
important role in the pathogenesis of these infections 
[3,5]. I t  is not clear, however, whether differences in 
temperature-dependent properties of Y entevocolitica 0:3 
are connected with the appearance of their arthrito- 
genicity. 
I: enterocolitica 0:3 301/86 plasmid-positive strain 
isolated from a patient [6] was used. The bacteria were 
cultured in tryptic soy agar (Difco, Detroit, Michigan, 
USA) at different temperatures (75OC and 37OC) and 
used as separate inocula. The experimental adult Lewis 
rats weighing 200-250 g (five in a group) were intra- 
articularly inoculated with 3 x lo4 bacteria in 0.1 mL 
saline. Synovial fluid aspirates were obtained from rats 
killed at 1, 3,  7, 14, 21, 43 and 60 days after challenge. 
Table 1 Findings in rat ankle joints after intra-articular injection of lo4 1; cnterorolitica 0:3 cells per joint 
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The experiments were repeated three times. 
Values are given as the mean 5 standard errors of five determinations 
'Significantly different from the control, p i0 .05.  
'Significantly different from 3 7 T  at the same day, p<O.OS. 
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Synovial fluid samples were cultured to isolate Y. entero- 
colitica on kevsinia selective agar (Oxoid, Basingstoke, 
UK) and examined with a Hyncel Counter HC-333 in 
order to determine the count of synovial leukocytes. 
Arthritis was defined as a visible joint swelling and 
evaluated by an increase in joint diameter and by 
determination of synovial exudative cell infiltration. 
The results (Table 1) showed that the acute 
phase (1-7 days postinfection) of Y entevocolitica 0:3 
experimental arthritis was related to the presence of 
bacteria within the joints. Bacteria grown at 25°C were 
detected in the joints up to the seventh day post- 
infection, and the synovial fluid response to these 
bacteria during this period showed an infiltration with 
leukocytes ranging from 3.1 x103 to 1.28x104/mL. 
In the early phase (1-3 days postinfection) the poly- 
morphonuclear leukocytes prevailed, in contrast to the 
later dominance of mononuclear cells. The incidence 
of swollen joints was greatest during the first week of 
the experiment. 
In contrast, bacteria grown at 37°C were found 
only on the first day postinfection and the experimental 
parameters (‘joint swelling and number of synovial 
exudative cells) were slightly increased. 
O f  interest was the maintenance of the chronic 
inflammatory reaction after disappearance of viable 
bacteria in both experimental groups. 
These data support the hypothesis of some authors 
[2,7] that it is not viable bacteria but some bacterial 
structures (e.g. lipopolysaccaride) that could persist in 
joints and trigger reactive arthritis. Of  special interest 
are differences in surface cell structures expressed at 
37°C and at temperatures below 30°C that affect the 
patho-genicity of Y enterocolitica 0:3. The acute arthritis 
induced by Y. enterocolitica 0:3 grown at 25°C developed 
more intensively than that induced by Y. enterocolitica 
0:3 grown at 37°C. Therefore, the experimental 
rat model of arthritis caused by Y. enterocolitica 0:3 
confirmed the importance of temperature regulation 
of yersinia pathogenic properties and their role in 
induction of reactive arthritis. 
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